The Federal commerce fee is investigating Amazon’s $three.9 billion acquisition of the predominant well being group One Medical, a transfer that would delay the completion of the deal.
each One Medical and Amazon obtained a request for added information Friday in reference to an FTC evaluation of the merger, in preserving with a submitting made with securities regulators by One Medical’s guardian, San Francisco-primarily based 1Life Healthcare Inc.
Amazon introduced plans in late July to buy One Medical, a concierge-form medical service with roughly one hundred ninety medical workplaces in 25 markets. final week, the e-commerce large mentioned it may shutter its personal hybrid digital in-house care service acknowledged as Amazon Care, a One Medical competitor, as a consequence of it wasn’t meeting prospects’ wants.
The One Medical deal, the predominant to be introduced beneath CEO Andy Jassy, was one other push into healthcare for Amazon following its acquisition of the web pharmacy PillPack for $750 million in 2018. teams calling for stricter antitrust legal guidelines shortly urged the FTC to dam the merger, arguing it may further broaden the agency’s huge market vitality.
An Amazon spokesperson declined to remark.
The FTC has already been investigating the signal-up and cancellation practices of Amazon Prime and has issued civil subpoenas in that case.
final yr, the agency requested unsuccessfully that FTC Chair Lina Khan step aside from separate antitrust investigations into its enterprise, arguing she can be biased. Khan was notable critic of Seattle-primarily based Amazon and fully different huge Tech firms earlier to assuming the chairmanship. As a Yale legal guidelines scholar in 2017, she wrote an influential examine titled “Amazon’s Antitrust Paradox.”